BerGenBio Balance Sheet Health
Financial Health criteria checks 3/6
BerGenBio has a total shareholder equity of NOK93.3M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK135.4M and NOK42.1M respectively.
Key information
0%
Debt to equity ratio
NOK 0
Debt
Interest coverage ratio | n/a |
Cash | NOK 117.35m |
Equity | NOK 93.32m |
Total liabilities | NOK 42.11m |
Total assets | NOK 135.43m |
Recent financial health updates
Companies Like BerGenBio (OB:BGBIO) Could Be Quite Risky
Jun 02Here's Why BerGenBio (OB:BGBIO) Must Use Its Cash Wisely
Dec 07BerGenBio (OB:BGBIO) Will Have To Spend Its Cash Wisely
Aug 24BerGenBio (OB:BGBIO) Will Have To Spend Its Cash Wisely
Feb 06Will BerGenBio (OB:BGBIO) Spend Its Cash Wisely?
Sep 26Will BerGenBio (OB:BGBIO) Spend Its Cash Wisely?
Jun 11Recent updates
Companies Like BerGenBio (OB:BGBIO) Could Be Quite Risky
Jun 02Here's Why BerGenBio (OB:BGBIO) Must Use Its Cash Wisely
Dec 07BerGenBio (OB:BGBIO) Will Have To Spend Its Cash Wisely
Aug 24BerGenBio (OB:BGBIO) Will Have To Spend Its Cash Wisely
Feb 06Will BerGenBio (OB:BGBIO) Spend Its Cash Wisely?
Sep 26Will BerGenBio (OB:BGBIO) Spend Its Cash Wisely?
Jun 11Is BerGenBio (OB:BGBIO) In A Good Position To Deliver On Growth Plans?
Feb 17We're Not Very Worried About BerGenBio's (OB:BGBIO) Cash Burn Rate
Sep 21It's Unlikely That The CEO Of BerGenBio ASA (OB:BGBIO) Will See A Huge Pay Rise This Year
Mar 13We're Interested To See How BerGenBio (OB:BGBIO) Uses Its Cash Hoard To Grow
Feb 11What Kind Of Investors Own Most Of BerGenBio ASA (OB:BGBIO)?
Dec 21Financial Position Analysis
Short Term Liabilities: BGBIO's short term assets (NOK135.1M) exceed its short term liabilities (NOK42.1M).
Long Term Liabilities: BGBIO's short term assets (NOK135.1M) do not cover its long term liabilities (NOK-1,000.0).
Debt to Equity History and Analysis
Debt Level: BGBIO is debt free.
Reducing Debt: BGBIO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BGBIO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BGBIO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 8.6% each year